Realcan Pharmaceutical Group Co., Ltd. (SHE:002589)
3.260
+0.040 (1.24%)
Sep 7, 2026, 3:04 PM CST
| Market Cap | 4.79B +12.5% |
| Revenue (ttm) | 7.17B -4.2% |
| Net Income | 9.04M +150.6% |
| EPS | 0.01 +90.9% |
| Shares Out | 1.47B |
| PE Ratio | 530.13 |
| Forward PE | n/a |
| Dividend | 0.00 (0.06%) |
| Ex-Dividend Date | Jun 30, 2026 |
| Volume | 66,296,678 |
| Open | 3.220 |
| Previous Close | 3.220 |
| Day's Range | 3.210 - 3.280 |
| 52-Week Range | 2.380 - 4.690 |
| Beta | 0.23 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 21, 2026 |